BioCurex, Inc.(fka BOCX)

[opportunityknocking]

Investors of BOCX, where there is smoke there is fire! RPC a similar biotech company that has had their DR-70 universal cancer marker compared to recaf has been resurrected. I hope Dr Moro is watching this closely. Look beyond the US borders. Do whatever it takes.

Here is an article from "Seeking Alpha," posted today about Radient Pharmaceuticals (previously AMDL) and please note their projected earnings..............................................

"Speaking of Radient Pharmaceuticals, we're told the company raised about $6 million dollars during their recent price run. The first half of the six million was raised at roughly $.40 per share and the second half at about $1.30 per share (roughly 6 million warrants at each of the price points).

Investors shorted heavily versus these 12 million shares and it appears many of them have been the source of the selling in the past few days. Most or all of this shorting is also naked since no one can find enough shares to borrow.

The simple equation means that a fully diluted share count would equal 34 million shares plus approximately 12 million warrants. That's where things are going to stay, versus 87 million shares if the company's debt had been converted. It now has all the funds it needs (roughly $10 million more in cash) to go cash flow positive in the third quarter and because of that, shareholders are not willing to let the debt convert in such an unfavorable fashion.

If the company makes the forecasted $3 million in earnings without any help from it's Chinese Pharma operations, then they are looking at +$.10 per share this year.

If RPC makes $30 million in sales next year, then you're looking at somewhere between $.50 and $.70 per share next year.

That's enough for fund managers and analysts to put shares at well over $5 per share with a 10x multiple on it for future discount- and that does NOT include the value of the company's Chinese Pharma asset. If you added that asset - which, again, is being looked at as an acquisition target by at least one publicly traded company - then that's an easy $25+ million or $.75 per share.

The sentiment is that the naked shorts (as many as 20 million shares worth) will start to feel a burning sensation as early as today. We'll see how long they can hold out before they have to start covering.

If that was all too complicated, then here is the Cliff's Notes version for you:

RPC = Still Greatly Undervalued (especially if the cancer test is as good as the peer-reviewed journal articles are saying it is).
http://finance.yahoo.com/q?s=RPC
..................................................................
<LOOK DR MORO OR DR BERGER AT THIS RECENT DEVELOPMENT>
NOW WE HAVE A BUSINESS MODEL AND A BLUEPRINT ON HOW TO GET US NOTICED AND GET THE SHARE PRICE ABOVE A DOLLAR. IF THEY CAN DO IT, WE CERTAINLY CAN!!! TIME TO GATHER UP THOSE IRONS IN THE FIRE AND MAKE IT HAPPEN!!! I WOULD ALSO SAY IT'S TIME TO REPAY YOUR LOYAL SHAREHOLDERS!!!